NDAORAL-28TABLET
Approved
Nov 1995
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4
Data completeness
4/8 — Partial
PREMPRO (conjugated estrogens and medroxyprogesterone acetate) by Pfizer is estrogen receptor agonists [moa]. First approved in 1995.
Drug data last refreshed 2d ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PREMPRO is an oral combination hormone replacement therapy (HRT) containing conjugated estrogens and medroxyprogesterone acetate, approved by the FDA in November 1995. It works through estrogen receptor agonism to address menopausal symptoms and hormone deficiency. The product is indicated for menopausal symptom management and is administered as a once-daily tablet. PREMPRO represents a foundational HRT approach in the estrogen pharmacologic class.
$0.0BPart D
Mechanism of Action
Estrogen Receptor Agonists
Pharmacologic Class:
Estrogen
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (4)
Study Comparing Premarin®/MPA, PREMPRO® and Provera® in Healthy Postmenopausal Women
Started Oct 2007
30 enrolled
Postmenopause
Bioequivalence Study of 3 New Formulations of Premarin/MPA Compared With Premarin/MPA (Prempro)
Started May 2007
Postmenopause
Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension
Started Jan 2007
92 enrolled
PostmenopauseHypertensionPre-Hypertension
Study Comparing Bioavailability of 3 New Formulations of Premarin/MPA With Premarin/MPA (PREMPRO) Reference Formulation
Started Nov 2006
Estrogen Replacement Therapy
Worked on PREMPRO at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.